Cumulative evidence suggests that KCNQ1OT1 promotes oncogenic phenotypes and chemoresistance of multiple cancers, including colon cancer, lung cancer, breast cancer, hepatocellular carcinoma, and tongue cancer [23–27]. Here, KCNQ1OT1 is linked to cancer.